ACA
CLBT icon

Apis Capital Advisors’s Cellebrite CLBT Stock Holding History

Apis Capital Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.5M Buy
1,470,000
+90,000
+7% +$1.19M 2.09% 19
2026
Q1 		$19M Buy
1,380,000
+560,000
+68% +$8.44M 2.93% 11
2025
Q4 		$14.8M Buy
820,000
+210,000
+34% +$3.77M 2.58% 16
2025
Q3 		$11.3M Buy
610,000
+266,000
+77% +$4.18M 2.5% 16
2025
Q2 		$5.5M Buy
344,000
+54,000
+19% +$963K 1.96% 16
2025
Q1 		$5.63M Buy
+290,000
New +$6.1M 2.73% 9
2024
Q3 		– Sell
-274,000
Closed -$3.27M – 35
2024
Q2 		$3.27M Buy
274,000
+50,000
+22% +$559K 2.42% 16
2024
Q1 		$2.48M Buy
224,000
+24,000
+12% +$245K 1.88% 15
2023
Q4 		$1.73M Buy
+200,000
New +$1.55M 1.82% 19

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Apis Capital Advisors's CLBT Position: Q2 2026 in Review

Apis Capital Advisors increased its Cellebrite (CLBT) stake by 6.5% in Q2 2026, buying an estimated $1.19M and bringing the position to 1,470,000 shares worth $21.5M. The position accounts for 2.09% of the portfolio, ranked #19.

Apis Capital Advisors first reported a position in CLBT in Q4 2023 and has held it in 9 quarters since. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Apis Capital Advisors held 1,470,000 shares of Cellebrite worth $21.5M as of Q2 2026.
  • Apis Capital Advisors bought 90,000 Cellebrite shares in Q2 2026, an estimated $1.19M.
  • Cellebrite made up 2.09% of Apis Capital Advisors's portfolio in Q2 2026, its #19 holding.
  • Apis Capital Advisors first reported a position in Cellebrite in Q4 2023 and has held it in 9 quarters since.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Apis Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.